In gliomas, the non‐vesicular secretion of glutamate through the cystine–glutamate exchanger (SLC7A11, xCT) is the primary mechanism responsible for the elevated concentration of extracellular glutamate. Here, SLC7A11 is linked to central nervous system cancer.